Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Clin Exp Immunol ; 187(1): 124-137, 2017 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-27324616

RESUMEN

CD4+ T helper cells are a valuable component of the immune response towards cancer. Unfortunately, natural tumour-specific CD4+ T cells occur in low frequency, express relatively low-affinity T cell receptors (TCRs) and show poor reactivity towards cognate antigen. In addition, the lack of human leucocyte antigen (HLA) class II expression on most cancers dictates that these cells are often unable to respond to tumour cells directly. These deficiencies can be overcome by transducing primary CD4+ T cells with tumour-specific HLA class I-restricted TCRs prior to adoptive transfer. The lack of help from the co-receptor CD8 glycoprotein in CD4+ cells might result in these cells requiring a different optimal TCR binding affinity. Here we compared primary CD4+ and CD8+ T cells expressing wild-type and a range of affinity-enhanced TCRs specific for the HLA A*0201-restricted NY-ESO-1- and gp100 tumour antigens. Our major findings are: (i) redirected primary CD4+ T cells expressing TCRs of sufficiently high affinity exhibit a wide range of effector functions, including cytotoxicity, in response to cognate peptide; and (ii) optimal TCR binding affinity is higher in CD4+ T cells than CD8+ T cells. These results indicate that the CD4+ T cell component of current adoptive therapies using TCRs optimized for CD8+ T cells is below par and that there is room for substantial improvement.


Asunto(s)
Linfocitos T CD4-Positivos/inmunología , Linfocitos T CD8-positivos/inmunología , Vacunas contra el Cáncer/inmunología , Terapia Genética/métodos , Antígeno HLA-A2/inmunología , Inmunoterapia Adoptiva/métodos , Neoplasias/terapia , Receptores de Antígenos de Linfocitos T alfa-beta/metabolismo , Antígenos de Neoplasias/metabolismo , Línea Celular , Citotoxicidad Inmunológica , Humanos , Proteínas de la Membrana/metabolismo , Neoplasias/inmunología , Unión Proteica , Receptores de Antígenos de Linfocitos T alfa-beta/genética , Transgenes/genética , Antígeno gp100 del Melanoma/metabolismo
2.
Biochem Soc Trans ; 34(Pt 6): 1041-5, 2006 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-17073746

RESUMEN

In this mini-review, we provide an overview of those PTPs (protein tyrosine phosphatases) that are relevant to the immune response, highlighting the function of a number of intracellular and transmembrane PTPs that have been identified as having important negative regulatory roles on distinct aspects of host immunity.


Asunto(s)
Inmunidad Innata , Linfocitos/inmunología , Proteínas Tirosina Fosfatasas/metabolismo , Células Dendríticas/inmunología , Homeostasis , Humanos , Sistema Inmunológico/fisiología , Modelos Inmunológicos , Linfocitos T/inmunología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA